If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Gout

Part II: Clinical Challenges and Renal Considerations in Managing Gout

By James W. Lohr, MD April 01, 2012

A case study involving a 65-year-old man with chronic kidney disease and acute attacks of pain, swelling, and erythema in the first metatarsophalangeal joint.

Renal Cysts More Common in Gout Patients

Jody A. Charnow March 30, 2012

Gout patients have an increased prevalence of simple renal cysts, and these cysts are associated with a decreased likelihood of kidney stone disease, according to Brazilian investigators.

Clinical Challenges and Renal Considerations In Managing Gout

By William F. Finn, MD March 01, 2012

A case study examines the treatment of hyperuricemia and gout in a 57-year-old postmenopausal renal transplant recipient with intermittent gout attacks.

A Nephrologic Perspective on the Management of Gout

By Anthony J. Bleyer, MD December 01, 2011

Gout is increasingly recognized in patients with chronic kidney disease, but the proper dosing regimen for traditional agents has not been well-studied in this patient group.

Renal Disease, Diabetes Linked to Uric Acid

Jody A. Charnow November 08, 2011

CHICAGO—Uncontrolled serum uric acid in patients with gout is associated with an increased risk of developing kidney disease and diabetes, according to the findings of two studies presented at the American College of Rheumatology annual meeting.

Allopurinol Can Be Used Safely in Renal Transplant Patients on Azathioprine

Jody A. Charnow April 09, 2011

VANCOUVER, B.C.—Allopurinol can be prescribed safely to treat recurrent gout in renal transplant recipients who are receiving azathioprine, British researchers reported.

FDA Takes On Unapproved Single-Ingredient Colchicine

Delicia Honen Yard November 16, 2010

The FDA has ordered a halt to the marketing of unapproved single-ingredient oral colchicine, a medication commonly used for the daily prevention of gout, to treat acute gout flare-ups, and for the treatment of familial Mediterranean fever.

Drug for Chronic Refractory Gout Approved

Delicia Honen Yard October 29, 2010

Savient Pharmaceuticals, Inc., of East Brunswick, N.J., has received FDA clearance to market Krystexxa (pegloticase) as a treatment for chronic gout in adult patients refractory to conventional treatment.